Supplements

Gastroenterology Data Trends 2021


 

Read Now

Contents Include:

  • Digital health in managing GI diseases
  • Emergence of live biotherapeutic products for C. difficile and beyond
  • AI and machine learning in GI practice
  • Eosinophilic esophagitis: Addressing the rise in incidence and treatment options
  • Racial and social diversity in GI practice
  • The gut-brain connection in IBS
  • Managing IBD in the backdrop of COVID-19
  • Noncardia gastric cancer risk: Racial/ethnic disparity, gastric precancerous changes, and refractory H. pylori
  • Rethinking management of alcohol-associated liver disease: The other fatty liver epidemic
  • Endoscopic bariatric and metabolic therapies for weight loss
  • The weight loss journey at University of Michigan

Read Now

Next Article:

An update on COVID-19 vaccine recommendations for patients with IBD